Clostridium difficile, also known as Clostridioides difficile and often referred to as C. difficile or C. diff, is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon.
Investigators
Open Research Studies for Recurrent C. difficile
IMT Database (U. Minnesota)
Enrolling: Yes
Principle Investigator: Monika Fischer, MD
Duration: 1 year
Patient Population: Adult patients receiving treatment for recurrent CDI
Study Intervention: Oral IMT or colonic IMT – questionnaire follow up for 1 year.
Interested in this study? Please contact the IBD research team: iuibd@iu.edu
Vedanta RestoratiVE303
Enrolling: Yes
Principle Investigator: Monika Fischer, MD
Duration: 24 weeks, 17 visits
Patient Population: Adult patients with recurrent C.Diff Infections.
Closed Recurrent C difficile Research Studies
Duration: 26 weeks
Patient Population: Adult patients with IBD and CDI undergoing an FMT as standard of care
Study Intervention: Bezlotuxumab Infusion in conjunction with FMT
Possibility of Placebo: 50% of not receiving Bezlotuxumab